Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

Abstract Background There is an increasing interest in HER2-low breast cancer with promising data from clinical trials using novel anti-HER2 antibody–drug conjugates. We explored the differences in clinicopathological characteristics and survival outcomes between HER2-low and HER2-IHC 0 breast cance...

Full description

Bibliographic Details
Main Authors: Hye Sung Won, Juneyoung Ahn, Yongseon Kim, Jin Sung Kim, Jeong-Yoon Song, Hong-Kyu Kim, Jeeyeon Lee, Heung Kyu Park, Yong-Seok Kim
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Breast Cancer Research
Subjects:
Breast cancer
HER2-low
Prognosis
Online Access:https://doi.org/10.1186/s13058-022-01519-x

Similar Items

Similar Items